GlassScriptPhysician profile
Heather M Trudeau
NPI 1790859858
$517.60
in general payments reported to CMS, 2019-2025
11 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $259 · 2024: $82.99 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.60 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $146.60 | 2023-2025 | Interstim |
| Coloplast Corp | $83.84 | 2025 | |
| Teleflex LLC | $82.07 | 2023 | Urolift |
| Novo Nordisk INC | $60.89 | 2024 | |
| Progenics Pharmaceuticals, INC. | $27.19 | 2023 | Pylarify |
| Endo USA, INC. | $26.18 | 2025 | Xiaflex |
| Axonics, INC. | $22.10 | 2024 | Axonics |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.73 | 2023 | Xifaxan |
| Antares Pharma, INC. | $18.16 | 2025 | Xyosted |
| Sumitomo Pharma America, INC. | $16.64 | 2023 | Gemtesa |
| Halozyme INC | $13.20 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Trudeau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.